Related Experiment Video
Updated: Aug 8, 2026
11:22
Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots
Published on: May 21, 2013
Mesenchymal stem cells: future source for reparative medicine
1Department of Medicine, Division of Cardiology and Institute for Cell Engineering (ICE), Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Congestive Heart Failure (Greenwich, Conn.)
|April 30, 2005
Summary
Mesenchymal stem cells (MSCs) show promise for treating heart failure by regenerating damaged heart muscle and blood vessels. Research explores MSCs for cardiomyogenesis and vasculogenesis in post-infarct hearts.
Area of Science:
- Regenerative Medicine
- Cardiovascular Research
- Stem Cell Biology
Background:
- Ischemic cardiomyopathy treatments focus on managing myocardial damage.
- Generating new myocardium and vasculature offers a novel therapeutic approach for heart failure.
- Stem cell research is pivotal for exploring new cardiac repair strategies.
Purpose of the Study:
- To review the role of mesenchymal stem cells (MSCs) in promoting cardiomyogenesis and vasculogenesis in post-infarct myocardium.
- To examine factors influencing MSC differentiation, delivery methods, and engraftment detection.
Main Methods:
- Review of animal and human clinical trials involving MSC transplantation.
- Analysis of studies on factors stimulating MSC differentiation.
- Evaluation of MSC delivery routes and engraftment detection techniques.
Main Results:
- MSCs exhibit multilineage potential, differentiating into myocardial and endothelial cells.
- MSCs possess immunomodulatory properties, evading host immune detection.
- Ease of MSC expansion in culture supports their therapeutic potential.
Conclusions:
- MSCs represent a promising stem cell source for cardiac repair in ischemic cardiomyopathy.
- Further research is needed to optimize MSC-based therapies for heart failure treatment.
Related Concept Videos
00:58Embryonic Stem Cells
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
01:19Mesenchymal Stem Cells
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
01:17Stem Cell Culture
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
00:57Embryonic Stem Cells
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.